Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

COUR Pharmaceutical Development Company, Inc.

2 clinical trials · 2 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by COUR Pharmaceutical Development Company, Inc.

RECRUITINGPhase 1 / Phase 2NCT06783309

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes...

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The...

Sponsor: COUR Pharmaceutical Development Company, Inc.Enrolling: 7220 locations
Type 1 Diabetes MellitusT1DT1DM+7
RECRUITINGPhase 1 / Phase 2NCT06106672

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-106.

Sponsor: COUR Pharmaceutical Development Company, Inc.Enrolling: 5417 locations
Myasthenia GravisGeneralized MyastheniaAChR Myasthenia Gravis+1